CYTK – cytokinetics, incorporated (US:NASDAQ)

News

Cytokinetics to Participate in March Investor Conferences [Yahoo! Finance]
Cytokinetics to Participate in March Investor Conferences
Assessing Cytokinetics (CYTK) Valuation After Recent Share Price Weakness And Aficamten Expectations [Yahoo! Finance]
Cytokinetics (CYTK) had its price target raised by Leerink Partners from $83.00 to $84.00. They now have an "outperform" rating on the stock.
Cytokinetics (CYTK) had its "neutral" rating reaffirmed by Bank of America Corporation.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com